Guggenheim lowered the firm’s price target on Argenx (ARGX) to $1,120 from $1,160 and keeps a Buy rating on the shares. FY25 financial results were largely as expected following the company’s pre-announcement, but the company’s update regarding three potential registrational readouts in 2026 further strengthens the quality and durability of the growth story, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx price target lowered to $1,247 from $1,317 at Wells Fargo
- Argenx price target raised to $940 from $915 at H.C. Wainwright
- Argenx price target raised to $944 from $925 at Citizens
- Argenx price target lowered to $1,227 from $1,248 at Stifel
- Vyvgart’s Strengthening MG Franchise and Pipeline Catalysts Support Buy Rating on Argenx